Pfizer pulls the plug on twice-daily obesity pill as study disappoints - Reuters


12/1/2023

Pfizer pulls the plug on twice-daily obesity pill as study disappoints  ReutersPfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects  CNBCPfizer Stops Developing Weight-Loss Pill  Bloomberg TelevisionPfizer slumps; pulls 2-dose obesity-drug study following patient reactions  TheStreetPfizer's Weight-Loss Drug Won't Enter a Phase 3 Trial. The Stock Drops.  Barron'sView Full Coverage on Google News...

Original

Categories: Financial | Google | Health | Obesity | Stock | Tech

Tags: coverage | drug | due | full | google | high | loss | news | rates | reuters | side | stock | study



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top